Changes

The data from known concentrations of the analyte can be used to externally produce a calibration curve which can then be used to infer the analyte concentrations of an unknown sample based on peak differences.

Additionally, an app has been developed which can measure the raw data in real-time during the measurement using Bluetooth. The data obtained can be automatically converted to the concentration of adalimumab in blood. The app provides graphs on current and past measurements, making the interpretation of the optimal drug usage straightforward to assess.